LOW-DOSE BROMOCRIPTINE THERAPY IN PARKINSONS-DISEASE

被引：9

作者：

PFEIFFER, RF ^{[1
]}

WILKEN, K ^{[1
]}

GLAESKE, C ^{[1
]}

LORENZO, AS ^{[1
]}

机构：

[1] UNIV NEBRASKA,MED CTR,DEPT PHARMACOL,OMAHA,NE 68105

来源：

ARCHIVES OF NEUROLOGY | 1985年 / 42卷 / 06期

关键词：

D O I：

10.1001/archneur.1985.04060060092015

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：586 / 588

页数：3

共 16 条

[1] BROMOCRIPTINE IN PARKINSONISM [J].

CALNE, DB ;

TEYCHENNE, PF ;

CLAVERIA, LE ;

EASTMAN, R ;

GREENACRE, JK ;

PETRIE, A .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942) :442-444

[2] ROLE OF BROMOCRIPTINE IN THE TREATMENT OF PARKINSONISM [J].

FAHN, S ;

COTE, LJ ;

SNIDER, SR ;

BARRETT, RE ;

ISGREEN, WP .

NEUROLOGY, 1979, 29 (08) :1077-1083

[3] EFFECT OF CB-154 (2-BROMO-ALPHA-ERGOCRYPTINE) ON PARALYSIS AGITANS COMPARED WITH MADOPAR IN A DOUBLE-BLIND, CROSSOVER TRIAL [J].

GERLACH, J .

ACTA NEUROLOGICA SCANDINAVICA, 1976, 53 (03) :189-200

[4]

GOLDSTEIN M, 1980, ERGOT COMPOUNDS BRAI, P75

[5]

GRIMES JD, 1983, CAN J NEUROL SCI, V10, P86

[6]

HORNYKIEWICZ O, 1982, DISORDERS NEUROHUMOR, P121

[7] STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)-AMPHETAMINE AND L-DOPA [J].

JOHNSON, AM ;

LOEW, DM ;

VIGOURET, JM .

BRITISH JOURNAL OF PHARMACOLOGY, 1976, 56 (01) :59-68

[8]

KARTZINEL R, 1976, LANCET, V2, P272

[9] RECEPTOR BASIS FOR DOPAMINERGIC SUPER-SENSITIVITY IN PARKINSONS-DISEASE [J].

LEE, T ;

SEEMAN, P ;

RAJPUT, A ;

FARLEY, IJ ;

HORNYKIEWICZ, O .

NATURE, 1978, 273 (5657) :59-61

[10] LONG-TERM EFFICACY OF BROMOCRIPTINE IN PARKINSON DISEASE [J].

LIEBERMAN, A ;

KUPERSMITH, M ;

NEOPHYTIDES, A ;

CASSON, I ;

DURSO, R ;

FOO, SH ;

KHAYALI, M ;

BEAR, G ;

GOLDSTEIN, M .

NEUROLOGY, 1980, 30 (05) :518-523

← 1 2 →